P-Selectivity, Immunity, and the Power of One Bit

We prove that P-sel, the class of all P-selective sets, is EXP-immune, but is not EXP/1-immune. That is, we prove that some infinite P-selective set has no infinite EXP-time subset, but we also prove that every infinite P-selective set has some infinite subset in EXP/1. Informally put, the immunity of P-sel is so fragile that it is pierced by a single bit of information. The above claims follow from broader results that we obtain about the immunity of the P-selective sets. In particular, we prove that for every recursive function f, P-sel is DTIME(f)-immune. Yet we also prove that P-sel is not \Pi_2^p/1-immune

Work distribution for the driven harmonic oscillator with time-dependent strength: Exact solution and slow driving

We study the work distribution of a single particle moving in a harmonic oscillator with time-dependent strength. This simple system has a non-Gaussian work distribution with exponential tails. The time evolution of the corresponding moment generating function is given by two coupled ordinary differential equations that are solved numerically. Based on this result we study the behavior of the work distribution in the limit of slow but finite driving and show that it approaches a Gaussian distribution arbitrarily well

Combined Effects of Atmospheric and Seafloor Iron Fluxes to the Glacial Ocean

Changes in the ocean iron cycle could help explain the low atmospheric CO2 during the Last Glacial Maximum (LGM). Previous modeling studies have mostly considered changes in aeolian iron fluxes, although it is known that sedimentary and hydrothermal fluxes are important iron sources for today's ocean. Here we explore effects of preindustrial-to-LGM changes in atmospheric dust, sedimentary, and hydrothermal fluxes on the ocean's iron and carbon cycles in a global coupled biogeochemical-circulation model. Considering variable atmospheric iron solubility decreases LGM surface soluble iron fluxes compared with assuming constant solubility. This limits potential increases in productivity and export production due to surface iron fertilization, lowering atmospheric CO2 by only 4 ppm. The effect is countered by a decrease in sedimentary flux due to lower sea level, which increases CO2 by 15 ppm. Assuming a 10 times higher iron dust solubility in the Southern Ocean, combined with changes in sedimentary flux, we obtain an atmospheric CO2 reduction of 13 ppm. The high uncertainty in the iron fluxes does not allow us to determine the net direction and magnitude of variations in atmospheric CO2 due to changes in the iron cycle. Our model does not account for changes to iron-binding ligand concentrations that could modify the results. We conclude that when evaluating glacial-interglacial changes in the ocean iron cycle, not only surface but also seafloor fluxes must be taken into account

Typification and authorship of Drosera intermedia (Droseraceae)

Drosera intermedia is lectotypified with the herbarium specimen on which the type drawing in the 1798 protologue was based. The collection history of the specimen, the history of the botanical drawing as original material, and the correct nomenclatural author and publication date of the name are presented based on historical notes and literature. Additionally, the global distribution of the species is given, including the first record from Africa

Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study

<p>Abstract</p> <p>Background</p> <p>Selective serotonin reuptake inhibitors (SSRI) decrease platelet-function, which suggests that SSRI use may increase the risk of post-surgical bleeding. Few studies have investigated this potential association.</p> <p>Methods</p> <p>We conducted a population-based study of the risk of re-operation due to post-surgical bleeding within two weeks of primary surgery among Danish women with primary breast cancer. Patients were categorised according to their use of SSRI: never users, current users (SSRI prescription within 30 days of initial breast cancer surgery), and former users (SSRI prescription more than 30 days before initial breast cancer surgery). We calculated the risk of re-operation due to post-surgical bleeding within 14 days of initial surgery, and the relative risk (RR) of re-operation comparing SSRI users with never users of SSRI adjusting for potential confounders.</p> <p>Results</p> <p>389 of 14,464 women (2.7%) were re-operated. 1592 (11%) had a history of SSRI use. Risk of re-operation was 2.6% among never users, 7.0% among current SSRI users, and 2.7% among former users. Current users thus had an increased risk of re-operation due to post-operative bleeding (adjusted relative risk = 2.3; 95% confidence interval (CI) = 1.4, 3.9) compared with never users. There was no increased risk of re-operation associated with former use of SSRI (RR = 0.93, 95% CI = 0.66, 1.3).</p> <p>Conclusions</p> <p>Current use of SSRI is associated with an increased risk of re-operation due to bleeding after surgery for breast cancer.</p

Influence of degree of specific allergic sensitivity on severity of rhinitis and asthma in Chinese allergic patients

<p>Abstract</p> <p>Background</p> <p>The association between sensitizations and severity of allergic diseases is controversial.</p> <p>Objective</p> <p>This study was to investigate the association between severity of asthma and rhinitis and degree of specific allergic sensitization in allergic patients in China.</p> <p>Method</p> <p>A cross-sectional survey was performed in 6304 patients with asthma and/or rhinitis from 4 regions of China. Patients completed a standardized questionnaire documenting their respiratory and allergic symptoms, their impact on sleep, daily activities, school and work. They also underwent skin prick tests with 13 common aeroallergens. Among the recruited subjects, 2268 provided blood samples for serum measurement of specific IgE (sIgE) against 16 common aeroallergens.</p> <p>Results</p> <p>Significantly higher percentage of patients with moderate-severe intermittent rhinitis were sensitized to outdoor allergens while percentage of patients sensitized to indoor allergens was increased with increasing severity of asthma. Moderate-severe intermittent rhinitis was associated with the skin wheal size and the level of sIgE to <it>Artemisia vulgaris </it>and <it>Ambrosia artemisifolia </it>(p < 0.001). Moderate-severe asthma was associated with increasing wheal size and sIgE response to <it>Dermatophagoides </it>(<it>D</it>.) <it>pteronyssinus </it>and <it>D. farinae </it>(p < 0.001). Moderate-severe rhinitis and asthma were also associated with increase in number of positive skin prick test and sIgE.</p> <p>Conclusions</p> <p><it>Artemisia vulgaris </it>and <it>Ambrosia artemisifolia </it>sensitizations are associated with the severity of intermittent rhinitis and <it>D. pteronyssinus </it>and <it>D. farinae </it>sensitizations are associated with increasing severity of asthma in China. Increase in number of allergens the patients are sensitized to may also increase the severity of rhinitis and asthma.</p

Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia

There is increasing clinical and molecular evidence for the role of hormones and specifically estrogen and its receptor in schizophrenia. A selective estrogen receptor modulator, raloxifene, stimulates estrogen-like activity in brain and can improve cognition in older adults. The present study tested the extent to which adjunctive raloxifene treatment improved cognition and reduced symptoms in young to middle-age men and women with schizophrenia. Ninety-eight patients with a diagnosis of schizophrenia or schizoaffective disorder were recruited into a dual-site, thirteen-week, randomized, double-blind, placebocontrolled, crossover trial of adjunctive raloxifene treatment in addition to their usual antipsychotic medications. Symptom severity and cognition in the domains of working memory, attention/processing speed, language and verbal memory were assessed at baseline, 6 and 13 weeks. Analyses of the initial 6-week phase of the study using a parallel groups design (with 39 patients receiving placebo and 40 receiving raloxifene) revealed that participants receiving adjunctive raloxifene treatment showed significant improvement relative to placebo in memory and attention/processing speed. There was no reduction in symptom severity with treatment compared with placebo. There were significant carryover effects, suggesting some cognitive benefits are sustained even after raloxifene withdrawal. Analysis of the 13-week crossover data revealed significant improvement with raloxifene only in attention/processing speed. This is the first study to show that daily, oral adjunctive raloxifene treatment at 120 mg per day has beneficial effects on attention/processing speed and memory for both men and women with schizophrenia. Thus, raloxifene may be useful as an adjunctive treatment for cognitive deficits associated with schizophrenia.TW Weickert, D Weinberg, R Lenroot, SV Catts, R Wells, A Vercammen, M O, Donnell, C Galletly, D Liu, R Balzan, B Short, D Pellen, J Curtis, VJ Carr, J Kulkarni, PR Schofield and CS Weicker